Vave is the product of around three years' in-house development and has quoted on more than 1.2 million risks since it began trading in May 2019, representing $2.2bn
Vave is the product of around three years' in-house development and has quoted on more than 1.2 million risks since it began trading in May 2019, representing $2.2bn